Keywords: upjohn, downgrade, because, concerns, regarding, side, effects

UPJOHN "DOWNGRADE"

Article | 16 March 1992

Print This

Because of concerns regarding side effects and their impact on the sales of Upjohn's sedative Halcion (triazolam), now around $260 million ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in